--- a
+++ b/clusters/9knumclustersv2/clust_1153.txt
@@ -0,0 +1,17 @@
+Recent (within  weeks of registration), current, or planned participation in another experimental drug study
+Current, recent (within  weeks of the first dose of this study), or planned participation in an experimental drug study with an experimental agent
+Current, recent (within  weeks of the administration of this study agent), or planned participation in another experimental therapeutic drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study other than a Genentech-sponsored bevacizumab cancer study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in any other experimental drug study
+Current, or recent (within  weeks of the first treatment of this study) cytotoxic chemotherapy (e.g. cisplatin, taxol) or experimental drug therapy, or planned participation in an experimental drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study
+Planned participation in any other experimental drug study
+Current, recent (within  weeks of the first treatment of this study), or planned participation in an experimental drug study (prevention trials are permitted if the trial is not testing a novel experimental agent)
+Current, recent (within  weeks of the administration of this study agent), or planned participation in an experimental drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study other than a Genentech-sponsored bevacizumab cancer study
+Current, recent (within  weeks of enrollment of this study), or planned participation in an experimental drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study other than a Genentech-sponsored bevacizumab cancer study
+Current, recent (within  weeks of enrollment of this study), or planned participation in an experimental drug study
+Recent (i.e., within the past  days prior to randomization) or current participation in another experimental drug study
+Current, recent (within  weeks of the first infusion of this study), or planned participation in an experimental drug study other than a Genentech-sponsored bevacizumab cancer study